Literature DB >> 10827957

Regulation of B lymphocyte and macrophage development by graded expression of PU.1.

R P DeKoter1, H Singh.   

Abstract

The ets family transcription factor PU.1 is required for the development of multiple lineages of the immune system. Using retroviral transduction of PU.1 complementary DNA into mutant hematopoietic progenitors, we demonstrate that differing concentrations of the protein regulate the development of B lymphocytes as compared with macrophages. A low concentration of PU. 1 protein induces the B cell fate, whereas a high concentration promotes macrophage differentiation and blocks B cell development. Conversely, a transcriptionally weakened mutant protein preferentially induces B cell generation. Our results suggest that graded expression of a transcription factor can be used to specify distinct cell fates in the hematopoietic system.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10827957     DOI: 10.1126/science.288.5470.1439

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  230 in total

1.  The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's disease.

Authors:  E Torlakovic; A Tierens; H D Dang; J Delabie
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

Review 2.  A genetic investigation of E2A function in lymphocyte development.

Authors:  J Hanrahan; L Pan; S Greenbaum; C Bradney; M Hjelmeland; M Dai; Y Zhuang
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

3.  Inhibition of CBP-mediated protein acetylation by the Ets family oncoprotein PU.1.

Authors:  Wei Hong; Alexander Y Kim; Sokun Ky; Carrie Rakowski; Sang-Beom Seo; Debabrata Chakravarti; Michael Atchison; Gerd A Blobel
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

4.  Functional PU.1 in macrophages has a pivotal role in NF-κB activation and neutrophilic lung inflammation during endotoxemia.

Authors:  Manjula Karpurapu; Xuerong Wang; Jing Deng; Hyesuk Park; Lei Xiao; Ruxana T Sadikot; Randall S Frey; Ulrich A Maus; Gye Young Park; Edward W Scott; John W Christman
Journal:  Blood       Date:  2011-09-21       Impact factor: 22.113

Review 5.  Factors and networks that underpin early hematopoiesis.

Authors:  Elinore M Mercer; Yin C Lin; Cornelis Murre
Journal:  Semin Immunol       Date:  2011-09-18       Impact factor: 11.130

6.  A microRNA expression signature of osteoclastogenesis.

Authors:  Toshifumi Sugatani; Jean Vacher; Keith A Hruska
Journal:  Blood       Date:  2011-01-27       Impact factor: 22.113

7.  Ex vivo expansion of human mobilized peripheral blood stem cells using epigenetic modifiers.

Authors:  Santosh Saraf; Hiroto Araki; Benjamin Petro; Youngmin Park; Simona Taioli; Kazumi G Yoshinaga; Emre Koca; Damiano Rondelli; Nadim Mahmud
Journal:  Transfusion       Date:  2014-11-02       Impact factor: 3.157

8.  Transcription factor-mediated lineage switching reveals plasticity in primary committed progenitor cells.

Authors:  Clare Heyworth; Stella Pearson; Gillian May; Tariq Enver
Journal:  EMBO J       Date:  2002-07-15       Impact factor: 11.598

9.  Epigenetic silencing of the c-fms locus during B-lymphopoiesis occurs in discrete steps and is reversible.

Authors:  Hiromi Tagoh; Alexandra Schebesta; Pascal Lefevre; Nicola Wilson; David Hume; Meinrad Busslinger; Constanze Bonifer
Journal:  EMBO J       Date:  2004-10-14       Impact factor: 11.598

10.  SOX2 is a dose-dependent regulator of retinal neural progenitor competence.

Authors:  Olena V Taranova; Scott T Magness; B Matthew Fagan; Yongqin Wu; Natalie Surzenko; Scott R Hutton; Larysa H Pevny
Journal:  Genes Dev       Date:  2006-05-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.